RecruitingNCT04599621

Unstable Angina Pectoris in Comorbidity With Anxiety-depressive Syndrome

Immunological Features of Unstable Angina Pectoris in Comorbidity With Anxiety-depressive Syndrome


Sponsor

Samarkand State Medical Institute

Enrollment

3 participants

Start Date

Nov 5, 2018

Study Type

OBSERVATIONAL

Conditions

Summary

Introduction: Today it is necessary to emphasize that coronary heart disease is often associated with anxiety disorders. Research over the years has shown several and sometimes surprising links between coronary heart disease and mental illness, and has even suggested that both of these phenomena may actually cause each other. However, the exact nature of these links has not yet been clearly established. Methods: The study included 202 patients with coronary artery disease, of whom 42 patients were with stable angina pectoris, they participated as a control group, and 160 patients with unstable angina pectoris, who made up the main group. Among them there are 102 women and 100 men between the ages of 30 and 88. The average age was 63.75 ± 11.37 years. All study participants had blood in the morning on fasting after 8-12 hours of fasting from the cubital vein. Determination of the level of cytokines TNF-α, IL-1β, IL-4 and IL-10 in blood serum by enzyme-linked immunosorbent assay (ELISA). All participants in the study had blood drawn in the morning on fasting after 8-12 hours of fasting from the cubital vein. The level of uric acid was determined on the CYAN Start apparatus using a unified method. When examining patients with unstable angina pectoris were used: hospital anxiety and depression scale \[Kozlova S.N. 2013\]. And also the Spielberger-Khanin scale \[Psychiatry - Hoffman A.G. 2010\], developed by Spielberger Ch.D. and adapted by Yu.L. Khanin. to assess cognitive functions \[Psychiatry - Gofman A.G. 2010\].


Eligibility

Plain Language Summary

Simplified for easier understanding

This study investigates the relationship between heart disease and anxiety or depression in patients with unstable chest pain (angina). It aims to understand how psychological conditions affect the progression and treatment of coronary artery disease, and whether addressing both the heart condition and mental health together leads to better outcomes for patients. **You may be eligible if...** - You have been diagnosed with coronary artery disease - You have unstable angina (chest pain that occurs at rest or with very little activity) or stable exertional angina (chest pain that comes on with physical effort) - You are willing and able to complete questionnaires as part of the study **You may NOT be eligible if...** - You do not wish to participate in the study - You are pregnant or breastfeeding - You have a severe or unstable health condition making completing questionnaires impractical or unsafe - You have had a recent stroke - You have a history of acute or chronic psychosis - You have another active acute illness or a chronic condition in a severe flare Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIAGNOSTIC_TESTCollection of blood samples to determine the level of certain cytokines (TNF-α, IL-1β, IL-4 and IL-10),Collection of blood samples to determine the level of uric acid

Collection of blood samples to determine the level of certain cytokines (TNF-α, IL-1β, IL-4 and IL-10) All study participants had blood in the morning on fasting after 8-12 hours of fasting from the cubital vein. Determination of the level of cytokines TNF-α, IL-1β, IL-4 and IL-10 in blood serum by enzyme-linked immunosorbent assay (ELISA). All participants in the study had blood drawn in the morning on fasting after 8-12 hours of fasting from the cubital vein. The level of uric acid was determined on the CYAN Start apparatus using a unified method.


Locations(1)

Zarina

Samarkand, Uzbekistan

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04599621


Related Trials